The reason for the outstanding final notice could be that it will be issued once she sold completely out. But I agree with those who see that as a concern as she was the one happily promoting the assets. Even getting fired wouldn't mean to have to sell all shares if there is an upside to come. Plus the remote chance that any possible new employer she will work for could make an offer should the sp remain that low.
But that is typically Hopper, leaving us sh guessing. And that opens the gate for speculations, assumptions, rumours......and the drop of the valuation.
All that could be avoided if there was transparency. If the assets of the 3 comps wouldn't have been progressed so well I would have sold out long time ago but in that regards I agree with Dalts, Pinch and Valueadd, the 3 comps have a huge risk / reward ratio.
GLTA
- Forums
- ASX - By Stock
- Ann: Notice of Extraordinary General Meeting/Proxy Form
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

The reason for the outstanding final notice could be that it...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $19.57K | 4.893M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 419507 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18587873 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 419507 | 0.004 |
40 | 26959271 | 0.003 |
16 | 15400505 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 18587873 | 22 |
0.006 | 13384684 | 15 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2390797 | 5 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online